Water For Injection

• Clinical trial on the virucidal activity of different oral antiseptics against respiratory viruses. Pending
  2024-515939-30-01 Phase IV 1 country Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela
• Double-blind randomized controlled study versus placebo to evaluate the efficacy of mono-administration of betamethasone in children with sy… Pending
  2024-518095-31-00 Phase III 1 country Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino
• A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting
  2025-524580-21-00 Phase II/III 1 country Inmunotek S.L.
• A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Safety of Epicutaneous Immunotherapy with DBV712 250 µg in 1-thr… Recruiting
  2025-521697-34-00 Phase III 4 countries Dbv Technologies
• Phase Ib study combining dinutuximab beta with induction chemotherapy regimens in patients with newly diagnosed high-risk neuroblastoma Recruiting
  2023-509673-22-00 Phase I/II 7 countries Prinses Maxima Centrum voor Kinderoncologie B.V.
• ViaskinTM Peanut Immunotherapy Trial to Evaluate Safety, Simplicity and Efficacy (VITESSE) Ended
  2022-502110-85-00 Phase III 5 countries Dbv Technologies
• A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutane… Ended
  2023-504942-75-01 Phase III 6 countries HAL Allergy B.V.
• A Study to Evaluate the Efficacy and Safety of LASN01 in Patients with Thyroid Eye Disease Ended
  2023-508161-32-00 Phase II 2 countries Lassen Therapeutics 1 Inc.
• Moisturiser effect on the skin barrier in atopic dermatitis Ended
  2023-508560-29-00 Phase II 1 country ACO Hud Nordic AB
• A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) Ended
  2022-502227-22-00 Phase II 7 countries Kezar Life Sciences Inc.
• Efficacy of a fixed combination of diclofenac 75 mg + thiocolchicoside 4 mg as solution for injection, in relieving back pain symptoms. Cont… Ended
  2024-518753-42-00 Phase III 2 countries Epifarma S.r.l.
• Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy of pre-surgical HPV9-valente vaccination… Ended
  2024-513704-34-00 Phase III 1 country Azienda Unita Sanitaria Locale Toscana Nord Ovest

Showing 1–12 of 12 trials